Life after SAINT.
Hallevi
Hen
H
Department of Neurology, Medical School, University of Texas, Houston, TX 77030, USA.
Aronowski
Jaroslaw
J
D000418:Albumins / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D017322:Clinical Trials, Phase II as Topic / Q000379:methods / Q000706:statistics & numerical data; D004311:Double-Blind Method; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D009474:Neurons / Q000473:pathology; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015424:Reperfusion; D020521:Stroke / Q000188:drug therapy* / Q000473:pathology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D017211:Treatment Failure
D000418:Albumins; D000975:Antioxidants; D001557:Benzenesulfonates; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; C503306:caffeinol; D002110:Caffeine; D000431:Ethanol; C120851:disufenton sodium; D010959:Tissue Plasminogen Activator; D008274:Magnesium; D005905:Glyburide